Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Healthcare Realty Trust (HR) Upgraded to Buy: What Does It Mean for the Stock?
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
Bears are Losing Control Over Healthcare Realty Trust (HR), Here's Why It's a 'Buy' Now
After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)
Healthcare Realty Trust Q2 Earnings Call Highlights
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
Healthcare Realty Trust (HR) Q2 FFO and Revenues Beat Estimates
Healthcare Realty Reports Second Quarter 2026 Results and Further Increases Full Year 2026 Guidance
Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
New Strong Buy Stocks for June 8th
Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
Healthcare Realty Trust: Betting On Outpatient Demand Growth, Lower Operator Risk (Upgrade)
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
Healthcare Realty Announces Proposed Exchangeable Senior Notes Offering